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http://dx.doi.org/10.1016/j.fjs.2014.
1682-606X/Copyright ª 2015, TaiwanSummary Background: Providing soft-tissue coverage after wide excision of dermatofibro-
sarcoma protuberans (DFSP) is always challenging; according to the literature, a skin graft is
often chosen as the first option. However, possible suboptimal functional and cosmetic results
have been noted.
Aims and objectives: We present our 10-year experience using pedicled or free flaps for recon-
struction after a wide excision of DFSP to provide adequate soft-tissue augmentation and
enhanced esthetic results.
Materials and methods: This was a retrospective study comprising 14 DFSP patients who were
treated between February 2003 and December 2013. All patients underwent a wide excision with
a 3-cm safe margin with immediate reconstruction, and a negative deep margin confirmed with a
frozen section. The reconstruction method included nine pedicled perforator flaps and five free
perforator flaps. All patients received adjuvant radiotherapy after surgery.
Results: Thepeak incidence thatoccurred in this serieswas thehighest in patients younger than30
years. None of the 14 patients exhibited recurrence, and themean follow-up timewas 30months.
Half of the patients exhibited DFSP distributed over the trunk; the patients in the series were pre-
dominantly male. A total of 13 flaps were successful except for one pedicled flap that failed from
venouscongestion;weused it in a salvageprocedurebyusing full-thickness skin graft for coverage.
Conclusion: A wide excision with a 3-cmmargin of safety with immediate reconstruction is a reli-
ablemethod for DFSP resection. Initiating adjuvant radiotherapymight reduce the chance of local
recurrence. To minimize the complications of skin graft, pedicled, or free flaps provide superior
functional outcome, soft-tissue augmentation, and esthetic results.
Copyright ª 2015, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.have no conflicts of interest to declare.
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Dermatofibrosarcoma protuberans 111. Introduction
Dermatofibrosarcoma protuberans (DFSP) is a rare dermal
mesenchymal tumor first described by Taylor in 1890; it
accounts for < 0.1% of all cutaneous tumors with an annual
incidence of approximately 4.2 cases per million per year in
the United States.1 Although DFSP can be found in all parts
of the body, the trunk is the most common site (up to 50% of
all cases); it is most common in middle-aged males. DFSP is
locally aggressive and rarely metastasizes distally or to
regional lymph nodes postoperatively. The pathogenesis
remains unclear, and no hereditary influence has been
identified. According to the guidelines of The National
Comprehensive Cancer Network, the standard treatment
involves a wide excision with a safety margin to adjacent
fascia. Local recurrence remains challenging; adjuvant
radiotherapy can be administered after a wide excision to
reduce the risk of local recurrence for patients with close
or positive margins. An oral tyrosine kinase inhibitor, ima-
tinib, has been approved for inoperable tumors, local re-
currences, and metastatic diseases. Skin graft has been
widely used after oncologic resections in most studies, but
it is associated with complications such as scar contracture,
graft ulceration or loss after radiation,2 movement re-
striction, and poor esthetic outcomes.
In this paper, we present a series of 14 DFSP patients
who underwent a wide excision and immediate recon-
struction with a perforator flap for providing excellent soft
tissue coverage as well as functional and esthetic
outcomes.2. Materials and methods
In a retrospective study between February 2003 and
December 2013, 14 patients were treated in E-da Hospital
Department of Plastic Surgery. All patients underwent a
wide excision with a 3-cm deep safe margin to investing
fascia followed by immediate reconstruction. A frozen
section of deep margin was sent to pathologist immediately
after excision of the tumor to confirm a free margin. The
reconstruction methods included pedicled and free perfo-
rator flaps, depending on the specific location and defect
size; all patients received adjuvant radiotherapy 4 weeks
after wound healing. All patients received a total radiation
dose ranging from 45 Gy to 50 Gy after the wound healed
during a 5-week period, as suggested by a radiologist. All
patient data, clinical information, surgical therapies, pa-
thology results, and follow-up information were reviewed
from case files.3. Results
The mean age of 14 patients was 41.29  14.01 years (range
18e62 years), and males were more dominant than females
at a ratio of 9:5. The peak incidence occurred at approxi-
mately the age of 30 years in five patients in this series.
Seven patients exhibited DFSP in the trunk, four patients in
the head and neck, and three patients in the lower and
upper extremities (see Table 1).Because of the possible unfavorable esthetic results and
movement restrictions after scar contracture resulting from
suboptimal outcomes, we did not consider skin graft as an
option of reconstruction.3 Immediate reconstruction with a
pedicled perforator flap was the first option. If no suitable
regional flap is available, a free anterolateral thigh (ALT)
perforator flap is a versatile option to provide adequate
soft-tissue augmentation and re-create anatomical struc-
tures after excision. We performed nine pedicled flaps and
five free flaps for soft-tissue defect coverage.
No recurrence of the tumor occurred after surgery in our
study, regardless of whether the patients exhibited a pri-
mary tumor, local recurrence, or inadequate excision. The
mean follow-up time was 30 months (range 18e68 months).
Two postoperative complications occurred in 14 pa-
tients. Patient 5 suffered from wound dehiscence after
radiotherapy but healed completely through secondary
intension. The propeller perforator flap in Patient 9
exhibited a total loss because of venous congestion, and a
salvage full-thickness skin graft from the congested flap
was performed to cover the defect. An ALT flap was used in
six cases; four were free flaps, and two were pedicled ALT
flaps. Primary closure of the donor site was achieved in four
patients; the other two required skin graft.4 All the pedi-
cled perforator flaps of the donor site achieved primary
closure except in Patient 9, for which skin graft was used to
cover the donor site. No debulking or revision procedures
were necessary for patients with pedicled or free flaps;
patients were satisfied with the surgical and esthetic
outcomes.
4. Case reports
4.1. Patient 4
A 55-year-old female patient exhibited a 3 cm  2 cm mass
over her left lower leg for 3 years. An incisional biopsy
revealed that it was DFSP. After a wide excision of the
tumor with a 3-cm margin, the frozen section appeared
margin free. A pedicled medial sural perforator flap
(9 cm  8 cm) was elevated to cover the defect, and the
donor site was closed through skin graft. She received
postoperative radiotherapy 4 weeks later. No local recur-
rence was detected during a 27-month follow-up period.
The cosmetic result was acceptable (see Fig. 1).
4.2. Patient 12
A 42-year-old female patient exhibited a scalp tumor for 4
years. She underwent excision at an outside clinic and pa-
thology proved it was DFSP with inadequate resection. She
underwent a wide excision of the tumor and the outer
cortex of the scalp bone. Immediate reconstruction with a
free ALT flap (10 cm  8 cm) was performed. Because of a
bulked flap in the thigh, we performed immediate thinning
of the ALT flap. The recipient vessel was the right superfi-
cial temporal vessel. The postoperative course was un-
eventful. The flap sufficiently tolerated the radiotherapy
well, and no debulking procedure was required. The patient
was satisfied with the cosmetic result, after a 24-month
follow-up period (see Fig. 2).
Table 1 Patient profile and results.
Patient
no./age
(y)/sex
Tumor location Margin Tumor origin Reconstruction method Tumor size/
skin paddle (cm)
Complication Follow-up
time (mo)
Recurrence
1/30/F Middle lower
abdomen
Free Primary Pedicled abdominal flap 3  1/X None 31 None
2/18/M R’t thigh Free Local
recurrence
Pedicled R’t ALT flap 3  2/9  5 None 21 None
3/38/M Right lower
abdomen
Free Primary Pedicled L’t ALT flap 5  3/20  10 Donor site skin graft 43 None
4/55/F L’t lower leg Free Primary Pedicled L’t medial
sural a. flap
3  2/9  8 Donor site skin graft 27 None
5/30/M Left upper back Free Inadequate
excision
Pedicled L’t dorsal
scapular a. flap
3  3/12  9 dehiscence after R/
T/secondary healing
31 None
6/50/F R’t upper back Free Local
recurrence
Pedicled L’t
thoracodorsal a. flap
5  4/22  10 None 26 None
7/27/M R’t lateral chest Free Primary Pedicled R’t lateral
thoracodorsal a. flap
3  3/16  8 None 23 None
8/30/F R’t superior
breast
Free Primary Pedicled R’t LD
myocutaneous flap
4  2/12  6 None 18 None
9/60/M L’t shoulder free Primary Pedicled L’t
thoracoacromial
a. flap
3  3/10  8 Flap failure/
salvage FTSG
21 None
10/31/M L’t upper back free Primary Free R’t trapezius
flap
7  3/18  9 None 33 None
11/55/M Scalp free Primary Free L’t ALT flap 2  1/6  6 None 68 None
12/42/F Scalp free Inadequate
excision
Free L’t ALT flap 4  2/10  8 None 24 None
13/50/M Scalp free Primary Free L’t ALT flap 4  3/15  8 None 42 None
14/62/M Left cheek free Primary Free L’t ALT flap 4  3/12  10 Donor site skin graft 18 None
a Z arterial; ALT Z anterolateral thigh; F Z female; FTSG Z full thickness skin graft; LD Z latissimus dorsi; L’t Z left; R’t Z right; M Z male; R/T Z radiotherapy.
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Figure 1 Patient 4 is a 55-year-old female. (A) A 3 cm  2 cm lesion over the left medial lower leg is shown. (B) A 9 cm  8 cm
pedicled medial sural flap. (C) The donor site is covered with split-thickness skin graft. (D) A good esthetic result with minimal scar
contracture over the skin graft area is seen.
Dermatofibrosarcoma protuberans 135. Discussion
DFSP is a rare dermal mesenchymal tumor but the most
common cutaneous sarcoma. Although DFSP can be found in
all parts of the body, the trunk is the most common site. In
our study, in half of the patients DFSP was prevalent in the
trunk; 23.1% exhibited DFSP in the head and neck, and
15.4% and 7.7% in the lower and upper extremities,
respectively. It affected males between the ages of 20
years and 50 years; the mean age in our series was 41.29
years. Initially, the lesion appears as a small nodule or
plaque-like object, but it grows rapidly into a mushroom-
like shape, typically yellow-brown in color. DFSP is char-
acterized by a locally aggressive behavior that can involve
surrounding tissues including fascia, muscle, and bone. No
muscle or bone involvement was observed in our series.
McPeak et al5 observed only 8.13% of underlying bone
involvement for DFSP. DFSP rarely metastasizes distally or
to regional lymph nodes postoperatively; the lung is the
primary site for distant metastasis.
The pathogenesis of DFSP remains unclear and no he-
reditary influence has been discovered. Several studies
have proposed that a history of trauma or persistent irri-
tation can be a presumptive cause of tumor occurrence.6
Recent molecular studies have found that a chromosomal
translocation involves 17q22; 22q13, related to a fusion ofthe genes COL1A1 and PDGFb. The fusion protein binds to
the PDGFb receptor then stimulates the emergence of
DFSP.8 Although a history of trauma was proposed as the
cause of DFSP, only Patient 9 exhibited such history.
DFSP spreads cutaneously or subcutaneously, but mag-
netic resonance imaging and ultrasound can provide only
limited information regarding this. Gross inspection is not
sufficient and requires an incisional or excisional biopsy for
confirmation. Diffuse infiltration of a spindle shape, CD43
positive fibroblast arranged in a storiform pattern can be
observed through histologic study. The peripheral exten-
sions of tumor cells have a bland appearance and make it
difficult to determine the margin histologically.
According to the 2012 National Comprehensive Cancer
Network guidelines, the recommendation for treatment
involves complete surgical excision to adjacent fascia with
immediate reconstruction.9 According to the literature, the
margin of safety varies between 1 cm and 5 cm. Based on
Mohs micrographic surgery (MMS), an incision of 1-2cm
margin and immunostaining were performed, and repeated
resection was performed if the margin was identified as
positive. MMS can be superior in soft-tissue preservation,
but it has not been proven to reduce local recurrence.10
Although recurrence can occur at surgical margins, we
have observed cases of recurrence beyond the original
lesion described in previous studies. We performed a wide
Figure 2 Patient 12 is a 42-year-old female. (A) A 4 cm  2 cm lesion after inadequate excision at another hospital is shown. (B,
C) Wide excision with a 3-cm margin and removed outer cortex. (D) A 10 cm  8 cm free anterolateral thigh flap with immediate
defatting. (E) Anastomosis to superficial temporal vessels. (F) Excellent soft-tissue augmentation and contour is seen.
14 T.-C. Chan et al.excision with a 3-cm safe margin and deep to fascia, which
has been recommended in numerous studies. The micro-
scopic spread of the tumor may contribute to a high local
recurrence. No recurrence was observed in this study.
Rutgers et al11 observed a 50% recurrence rate, which was
reduced to 13% after an adequately wide excision. We sent
specimen from the deep margin for frozen section for all
cases in this series. The data from the frozen section were
not comparable to a pathological report, but indicated
whether the resection was adequate. An invasion of DFSP
can affect subcutaneous tissue, muscle, deep fascia, and
bone. We performed a wide excision deep to the investing
fascia, which is often less than 3 cm deep. To cover the
muscle and the exposed underlying bone, we used flap
reconstruction instead of skin graft to maintain function-
ality and prevent disability. DFSP is clinically benign but
pathologically malignant; we performed resection again if
recurrence occurred. We did not use skin graft as a
reconstructive option in this study because of its esthetic
and functional disadvantages. However, in cases with an
unfavorable general condition, lesion sites without func-
tional restriction, and in easily concealed areas, skin graft
should be considered an option because of several advan-
tages such as a quick sighting of recurrence, easy post-
operative care, lower cost, shorter surgery time, and
minimal chance of reconstructive failure.
Local recurrence remains challenging; adjuvant radio-
therapy can be administered after a wide excision to
reduce the risk of local recurrence in patients with close or
positive margins. DFSP is radiosensitive and disposed to
excellent local control.12 radiotherapy is recommended as
a systemic adjuvant treatment to reduce the risk of localrecurrence.13 Adjuvant radiotherapy has been shown to
enable effective control of local recurrence even for posi-
tive margins. For patients who are not candidates for sur-
gical resection, radiotherapy is recommended in the
National Comprehensive Cancer Network guidelines. The
chance of radiation toxicity is low, but the benefit must be
weighed against the risk.12
Although radiotherapy can be used for a positive margin
or to reduce local recurrence, the most crucial factor in
preventing recurrence is obtaining a negative margin
through a wide excision. Castle et al12 stated that 93% of
patients with a history of multiple recurrence and positive
margins, combining surgical excision and adjuvant radio-
therapy, exhibited a 10-year actuarial local control. We
send resected tumor to a pathologist for frozen section to
confirm a negative margin before wound coverage and
allowed superior local control and reduced the recurrence
rate.
The fusion gene COL1A1-PDGFb resulting from trans-
location t(17:22) is present in > 90% of DFSPs. Inhibitors of
this pathway may become a nonsurgical option in the
future. The oral tyrosine kinase inhibiter, imatinib, has
exhibited a favorable response rate in unresectable and
metastatic DFSP studies.4 Although imatinib should not be
used to reduce the surgical margin, the current National
Comprehensive Cancer Network guideline recommends it
for unresectable diseases, positive surgical margins,
recurrent diseases in critical functional and cosmetic areas,
and metastatic diseases.10
There is no standard staging for DFSP. The primary tumor
can be considered Stage I, regional lymph node metastasis
as Stage II, and distant metastasis as Stage III.9 Although
Dermatofibrosarcoma protuberans 15DFSP rarely distally metastasizes and the reported 5-year
survival is > 99%, most patients with metastatic disease
die within 2 years. The most crucial prognostic factor is to
obtain a negative surgical margin. Lesions > 10 cm,
involving a deeper structure, positive margin, and multiple
recurrences share a higher risk of local recurrence and
distant metastasis. The overall survival rates for both 5
years and 10 years were 98% with a negative margin exci-
sion and adjuvant radiotherapy.12,14
According to previous studies, numerous surgeons have
used skin graft after tumor resection. Scar contracture,
hyperpigmentation, ulceration, and partial graft loss have
often occurred after adjuvant radiotherapy.15 Although skin
graft tolerated the adjuvant radiotherapy after complete
healing, we still had to wait for 8 weeks after the operation
for improved results.16 Nevertheless, the loss of skin graft is
considerably increased after a single dose of  25 Gy, even
after complete healing within 4 weeks.2 Numerous surgeons
do not advocate skin graft for oncologic reconstruction if
adjuvant radiotherapy is required. With the refinement of
surgical techniques, it is possible to use regional or free flaps
to improve the esthetic results and functional outcomes for
oncologic reconstruction with a high success rate.17 Nearby
pedicled perforator flaps can reconstruct the defect with
anatomically similar tissue to resolve the color mismatch
and volume deficiency of the skin graft. Rarely, perforator
flaps require a debulking procedure and an excellent
esthetic outcome can be achieved. Faster wound healing
allows patients to initiate radiotherapy 4 weeks after an
operation, compared with 8 weeks after having undergone a
skin graft. Perforator flaps provide an adequate volume and
superior resistance to radiotherapy-induced contracture,
ulceration, and partial loss, and also eliminate secondary
surgeries. Although > 80% of the ALT flap donor sites could
be primarily closed, we did not achieve primary closure in
three patients. Overall, the donor sites with a flap width-to-
thigh circumference ratio of < 16% can be primarily
closed.17 Skin graft was used to cover the donor sites in
those three patients. Furthermore, skin graft was implanted
on the donor site and did not result in any restriction of
movement after healing. An ALT flap recently became the
prime-example flap for soft-tissue reconstruction and could
be the first choice for free-tissue transfer. To improve
donor-site esthetics, a remainder island ALT flap from the
distal portion, which is based on a retrograde pedicle, can
be used to close in a V-Y advancement manner.17 Up to 16%
of the circumference can be primarily closed for improve-
ment of the scar. It can be harvested as myocutaneous or
fasciocutaneous flaps according to the defect requirement,
has long and reliable pedicles for microanastomosis or even
for transfer as a regional flap, has a primary closed donor
site with minimal morbidity, and the scar can be easily
hidden underneath clothing.36. Conclusion
A wide excision with a 3-cm margin of safety with imme-
diate reconstruction is a reliable method for DFSP resec-
tion. To minimize the chance of local recurrence, a
negative margin should be confirmed through a frozen
section prior to wound coverage. Adjuvant radiotherapycan be initiated to reduce the local recurrence to 4 weeks
with perforator flaps compared with a skin graft. In addi-
tion, perforator flaps offer superior resistance to radiation-
induced skin ulceration and provide adequate tissue to
prevent restriction of movement through contracture;
furthermore they provide excellent functional outcomes
and esthetic results.
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